Avion Wealth’s Corcept Therapeutics CORT Stock Holding History

Avion Wealth’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	–	–	1295
2025 Q3	$0	Sell	7 -16	-70%	-$1.16K	﹤0.01%	1257
2025 Q2	$1K	Buy	+23	New	+$1.67K	﹤0.01%	934

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avion Wealth's CORT Position: Q4 2025 in Review

Avion Wealth sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 7 shares.

Avion Wealth first reported a position in CORT in Q2 2025 and held it in 2 quarters. The position peaked at $1K in Q2 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

Avion Wealth reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
Avion Wealth sold 7 Corcept Therapeutics shares in Q4 2025.
Avion Wealth first reported a position in Corcept Therapeutics in Q2 2025 and held it in 2 quarters.
Avion Wealth's Corcept Therapeutics position peaked at $1K in Q2 2025.
389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Avion Wealth's 13F filing for Q4 2025, filed 23 Jan 2026.